BioHorizons, Inc. has just filed to withdraw its filing for an initial public offering citing unfavorable market conditions. This company initially filed back in 2010 for an IPO of up to $100 million.
BioHorizons, Inc. is a medical technology company focused on developing, manufacturing and marketing a broad and comprehensive line of dental implants, as well as hard and soft tissue regeneration products, for the replacement of missing teeth.
The Form RW noted, “Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), BioHorizons, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of its Registration Statement on Form S-1 (Registration No. 333-167722), together with all exhibits and amendments thereto (the “Registration Statement”). The Registrant is requesting such withdrawal because of unfavorable market conditions that would adversely affect the offering of the shares of common stock, par value $0.0001 per share, covered by the Registrant Statement. No securities were sold or will be sold under the Registration Statement. The Registration Statement has not been declared effective by the Commission.”
Another medical technology IPO has formally fallen by the wayside.
JON C. OGG
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks